Aytu Biopharma, Inc. (AYTU)
2.37
+0.12
(+5.33%)
USD |
NASDAQ |
Dec 10, 14:44
Aytu Biopharma Profit Margin (Quarterly): 14.15% for Sept. 30, 2025
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Omeros Corp. | -- |
| GeoVax Labs, Inc. | -- |
| Vistagen Therapeutics, Inc. | -7.53K% |
| Precigen, Inc. | -5.01K% |
| Daré Bioscience, Inc. | -154.9K% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -48.36% |
| Return on Assets | -10.99% |
| Return on Invested Capital | -26.96% |
| Gross Profit Margin (Quarterly) | 62.95% |
| Operating Margin (Quarterly) | -10.83% |
| Return on Net Operating Assets | -13.98% |